Walleye Capital’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,100
Closed -$74.3K 4696
2026
Q1
$74.3K Sell
2,100
-25,500
-92% -$791K ﹤0.01% 3778
2025
Q4
$772K Buy
27,600
+15,300
+124% +$458K ﹤0.01% 2638
2025
Q3
$369K Buy
+12,300
New +$347K ﹤0.01% 2839
2023
Q4
Sell
-300
Closed -$8.4K 4893
2023
Q3
$8.4K Buy
+300
New +$8.79K ﹤0.01% 4504
2020
Q1
Sell
-1,000
Closed -$20K 870
2019
Q4
$20K Buy
+1,000
New +$19.9K ﹤0.01% 1601
2019
Q2
Sell
-8,400
Closed -$307K 1693
2019
Q1
$307K Buy
+8,400
New +$277K 0.05% 589

Other funds holding ALKS

Walleye Capital's ALKS Position: Q2 2026 in Review

Walleye Capital sold out of Alkermes (ALKS) in Q2 2026, closing a stake of 5,029 shares — an estimated $178K sold.

Walleye Capital first reported a position in ALKS in Q1 2019 and held it in 10 quarters. The position peaked at $2.57M in Q2 2022. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Walleye Capital reported no remaining Alkermes position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 5,029 Alkermes shares in Q2 2026, an estimated $178K.
  • Walleye Capital first reported a position in Alkermes in Q1 2019 and held it in 10 quarters.
  • Walleye Capital's Alkermes position peaked at $2.57M in Q2 2022.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.